Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene
The objective of this study was to increase the oral bioavailability of Raloxifene having an absolute bioavailability only 2% due to extensive first pass hepatic metabolism by incorporating it in Solid Lipid Nanoparticles (SLNs). The optimized RSLNs prepared by Ultrasonic Emulsification and Low Temp...
Saved in:
Main Authors: | B Divyakant Patel (Author), R Valay Modi (Author), N Alok Thakkar (Author), A Arpita Patel (Author), P Hetal Thakkar (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system
by: Hetal Thakkar, et al.
Published: (2011) -
Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement
by: Hetal Paresh Thakkar, et al.
Published: (2011) -
Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability
by: Xinhui Du, et al.
Published: (2021) -
Enhancing Oral Bioavailability of Simvastatin Using Uncoated and Polymer-Coated Solid Lipid Nanoparticles
by: Amira E. Abd-Elghany, et al.
Published: (2024) -
Raloxifene/SBE-β-CD Inclusion Complexes Formulated into Nanoparticles with Chitosan to Overcome the Absorption Barrier for Bioavailability Enhancement
by: Zaihua Wang, et al.
Published: (2018)